Role For Gefitinib In Asian Nonsmokers With Lung Cancer Established
Tuesday, September 16, 2008 - 10:29
in Health & Medicine
The targeted therapy gefitinib should be considered a first-line therapy for nonsmoking Asian patients with adenocarcinoma of the lung, one of the most common types of lung cancer, suggests a presentation at the 33rd Congress of the European Society for Medical Oncology.